Oncorena`s New Issue of Shares Fully Subscribed
26 Jun 2025 //
PR NEWSWIRE
Oncorena receives FDA approval to initiate studies in the US
18 Mar 2025 //
PR NEWSWIRE
Oncorena`s first patient treated with ONC175 in clinical phase I/II trial
04 Sep 2023 //
PR NEWSWIRE
Oncorena Initiates Phase I-II Clinical Trial with Orellanine
01 Feb 2022 //
BIOSPACE
Oncorena Secures Financing of the Company`s Continued Development of Orellanine
22 Dec 2021 //
PRNEWSWIRE

Market Place
Sourcing Support